FindTrial
Sign In

Comprehensive Staging System for Postoperative Stratification of Pancreatic Ductal Adenocarcinoma

Comprehensive Staging System for Postoperative Stratification of Pancreatic Ductal Adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118611
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Time and Centre: Patients undergoing radical pancreatic cancer surgery at West China Hospital, Sichuan University between September 2018 and October 2024. Resection Quality: Cases of radical surgery confirmed as R0 resection.

Exclusion criteria

Exclusion criteria: 1. Non-curative resection: such as palliative surgery or debulking surgery. 2. R1/R2 resection margins. 3. Missing key indicators: absence of CA19-9 test values or adjuvant therapy records. 4. Perioperative mortality: death occurring within 30 days post-surgery.

Design outcomes

Primary

MeasureTime frame
Disease free survival, DFS;AUC;—

Countries

China

Contacts

Public ContactDan Cao

West China Hospital, Sichuan University

caodan@scu.edu.cn+86 189 8060 5963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026